Literature DB >> 21960882

Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies.

Neal J Schamberg1, Gerond V Lake-Bakaar.   

Abstract

Within the past decade, it has been recognized that a majority of patients with essential mixed cryoglobulinemia (MC) are chronically infected with hepatitis C virus (HCV). Although the underlying mechanisms have not been fully elucidated, cryoglobulin formation is clearly linked to the attempt of the host to clear the significant quantities of virions generated daily by the chronic infection. This review summarizes the current understanding of the relationship between chronic HCV infection and the development of MC, and discusses the interaction between the immune system and HCV and how this interaction can lead to the development of lymphoproliferative disorders.

Entities:  

Keywords:  B lymphocytes; cryoglobulinemia; hepatitis C virus

Year:  2007        PMID: 21960882      PMCID: PMC3104260     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  97 in total

1.  Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.

Authors:  José-Angel Hernández; Raúl Diloy; David Salat; Neus del Río; Xavier Martínez; Josep-María Castellví
Journal:  Haematologica       Date:  2003-06       Impact factor: 9.941

Review 2.  B cell-ablative therapy for the treatment of autoimmune diseases.

Authors:  Dhavalkumar D Patel
Journal:  Arthritis Rheum       Date:  2002-08

3.  Cryoglobulinemia.

Authors:  Enrica Morra
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

4.  B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection.

Authors:  M Fabris; L Quartuccio; S Sacco; G De Marchi; G Pozzato; C Mazzaro; G Ferraccioli; T S Migone; S De Vita
Journal:  Rheumatology (Oxford)       Date:  2006-05-30       Impact factor: 7.580

5.  Chemical analyses of cryoglobulins.

Authors:  A C Wang; J V Wells; H H Fudenberg
Journal:  Immunochemistry       Date:  1974-07

6.  Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis.

Authors:  Maurizio Carbonari; Elisabetta Caprini; Tiziana Tedesco; Francesca Mazzetta; Valeria Tocco; Milvia Casato; Giandomenico Russo; Massimo Fiorilli
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

7.  Interaction of complement solubilized complexes with mouse peritoneal macrophages and their clearance and tissue uptake.

Authors:  N Takahashi; T Fujita; Y Takata; N Tamura
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

8.  Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.

Authors:  Ming-Shen Dai; Tsu-Yi Chao; Woei-Yau Kao; Rong-Yaun Shyu; Tan-Mei Liu
Journal:  Ann Hematol       Date:  2004-08-25       Impact factor: 3.673

9.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.

Authors:  R Misiani; P Bellavita; D Fenili; G Borelli; D Marchesi; M Massazza; G Vendramin; B Comotti; E Tanzi; G Scudeller
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

10.  Efficacy and safety of rituximab in type II mixed cryoglobulinemia.

Authors:  Francesco Zaja; Salvatore De Vita; Cesare Mazzaro; Stefania Sacco; Daniela Damiani; Ginevra De Marchi; Angela Michelutti; Michele Baccarani; Renato Fanin; Gianfranco Ferraccioli
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

View more
  10 in total

1.  Hepatitis C virus positive patient diagnosed after detection of atypical cryoglobulin.

Authors:  Belkiz Ongen; Fehime Benli Aksungar; Bahattin Cicek; Isin Akyar; Abdurrahman Coskun; Mustafa Serteser; Ibrahim Unsal
Journal:  World J Clin Cases       Date:  2016-03-16       Impact factor: 1.337

2.  Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.

Authors:  Poonam Mathur; Benjamin Emmanuel; Michael Sneller; Xiaozhen Zhang; Bhawna Poonia; Shyamasundaran Kottilil
Journal:  J Med Virol       Date:  2018-01-04       Impact factor: 2.327

3.  Mixed cryoglobulinemia: a diagnostic and therapeutic challenge.

Authors:  Maria Túlio; Liliana Carvalho; Tiago Bana E Costa; Cristina Chagas
Journal:  BMJ Case Rep       Date:  2017-05-10

4.  Decline of cellular activation in non-B cells after rituximab treatment in hepatitis C-associated mixed cryoglobulinemia vasculitis.

Authors:  B Emmanuel; N Sidique; X Zhang; B Poonia; M C Sneller; S Kottilil
Journal:  J Viral Hepat       Date:  2016-09-25       Impact factor: 3.728

5.  Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile.

Authors:  Martha Minopetrou; Emilia Hadziyannis; Melanie Deutsch; Maria Tampaki; Asimina Georgiadou; Eleni Dimopoulou; Dimitrios Vassilopoulos; John Koskinas
Journal:  Clin Vaccine Immunol       Date:  2013-03-06

6.  Dynamics of serum α-fetoprotein in viral hepatitis C without hepatocellular carcinoma.

Authors:  Teodora Isac; Sebastian Isac; Simona Ioanitescu; Enyedi Mihaly; Maria-Daniela Tanasescu; Daniela Gabriela Balan; Adrian Tulin; Laura Iliescu
Journal:  Exp Ther Med       Date:  2021-05-12       Impact factor: 2.447

Review 7.  Hepatitis C virus as a systemic disease: reaching beyond the liver.

Authors:  Kirat Gill; Hasmik Ghazinian; Richard Manch; Robert Gish
Journal:  Hepatol Int       Date:  2015-12-10       Impact factor: 6.047

8.  Interleukin-17A and B-cell activating factor in chronic hepatitis C patients with or without asymptomatic mixed cryoglobulinemia: effects of antiviral treatment and correlations with vitamin D.

Authors:  Polydoros Konstantinides; Alexandra Alexopoulou; Emilia Hadziyannis; Theoni Kanellopoulou; Spyridon P Dourakis
Journal:  Ann Gastroenterol       Date:  2018-09-14

Review 9.  Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.

Authors:  So Mi Kim; Il Han Song
Journal:  Korean J Intern Med       Date:  2018-06-28       Impact factor: 2.884

Review 10.  Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders.

Authors:  Rita Moretti; Mauro Giuffrè; Nicola Merli; Paola Caruso; Stefano Di Bella; Claudio Tiribelli; Lory Saveria Crocè
Journal:  Brain Sci       Date:  2021-11-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.